Phase II Docetaxel / Carboplatin / XRT + Surgical Resection in Stage III NSCLC

NCT00238615 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

13

Enrollment

OTHER

Sponsor class

Stopped low accrual

Conditions

Lung Cancer
Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: Docetaxel
DRUG: Carboplatin
PROCEDURE: Radiation therapy
PROCEDURE: Surgical resection

Sponsor

Stanford University

Collaborators

[object Object]